当前位置: 首页 > 期刊 > 《新医学》 > 201712
编号:13606583
维持性血液透析患者合并血管钙化情况的观察(3)
http://www.100md.com 2017年12月1日 《新医学》 201712
     参考文献

    [1]Nolan CR.Strategies for improving long-term survival in patients with ESRD.J Am Soc Nephrol,2005,6(Suppl 2):S120-S127.

    [2]Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman RP, Block GA, Raggi P.Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients.Kidney Int,2006,70(9):1623-1628.

    [3]Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl,2009,8(113):S1-S130.

    [4]Verbeke F, Van Biesen W, Honkanen E, Wikstrm B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, Rensma PL; CORD Study Investigators.Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.Clin J Am Soc Nephrol,2011,6(1):153-159.

    [5]Inaba M. Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients//Chronic Kidney Diseases-Recent Advances in Clinical and Basic Research. Switzerland: Karger Publishers, 2015, 185: 15-21.

    [6]吳瑕,孙本贵. 正常范围血清高磷浓度对慢性肾脏病患者心血管钙化的影响. 新医学,2010,41(11):732-734,761.

    [7]涂曦文,彭佑铭,唐东兴,谭太发,李丽文. 维持性血液透析患者血管钙化及相关因素分析. 中国动脉硬化杂志,2015,23(6):613-616.

    (收稿日期:2017-08-20)

    (本文编辑:林燕薇), 百拇医药(刘红勇 张运强 李敏佳 李胜荣 廖学渊 廖志波 洪冬梅 吴勇林)
上一页1 2 3